Home | Sitemap | Search | ContactA- A A+
   
 
    Public Member Support us  
 

IBCSG 27-02 / BIG 1-02 (CALOR) 

A randomized clinical trial of adjuvant chemotherapy for radically resected loco-regional relapse of breast cancer

Chemotherapy as Adjuvant for LOcally Recurrent (CALOR)

Chemotherapy vs. observation

DESIGN

Design 27-02

Results & Publications


Publications

Study Chairs
Prof. Stefan Aebi - Bern, Switzerland
Dr. Irene Wapnir - Stanford, USA

Statistician
Dr. Meredith Regan

Lead Trial Coordinator
Holly Shaw

Data Managers
Karolyn Scott

IBCSG Data Management Center/FSTRF
4033 Maple Road
Amherst, New York 14226 USA
Phone: +1 716 834 0900
Fax: +1 716 833 3990
Email: ibcsg27@fstrf.org

Date of Activation
July 31, 2002

Targeted Accrual
977 patients


Results Publications Results & Publications
Other Pathology


News

18.03.2017:
The next IBCSG Annual Meeting will take place in Vienna, Austria on March 18 and 19, 2017 .

15.03.2017:
15th St.Gallen International Breast Cancer Conference 15-18 March 2017 in Vienna/Austria People

30.09.2016:
Benefiz-Gala mit Spitzenkoch Anton Mosimann Freitag 30. September 2016 im Park Hyatt

All News

 
  Print